Experimental and Molecular Medicine

Papers
(The H4-Index of Experimental and Molecular Medicine is 48. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-10-01 to 2024-10-01.)
ArticleCitations
The mechanism of HMGB1 secretion and release330
Zebrafish as an animal model for biomedical research235
Type I and III interferon responses in SARS-CoV-2 infection210
On the origin and evolution of SARS-CoV-2198
Advanced glycation end products (AGEs) and other adducts in aging-related diseases and alcohol-mediated tissue injury182
Hepatocellular carcinoma: old friends and new tricks180
The role of TDP-43 propagation in neurodegenerative diseases: integrating insights from clinical and experimental studies176
Stress and the dopaminergic reward system175
Interplay between interleukin-6 signaling and the vascular endothelium in cytokine storms156
Innate immune sensing of coronavirus and viral evasion strategies153
Antibiotic resistome from the One-Health perspective: understanding and controlling antimicrobial resistance transmission151
The aftermath of the interplay between the endoplasmic reticulum stress response and redox signaling144
Cytosolic escape of mitochondrial DNA triggers cGAS-STING-NLRP3 axis-dependent nucleus pulposus cell pyroptosis137
Protein arginine methyltransferases: promising targets for cancer therapy135
Tailoring photosensitive ROS for advanced photodynamic therapy132
Necroptosis molecular mechanisms: Recent findings regarding novel necroptosis regulators129
Slimy partners: the mucus barrier and gut microbiome in ulcerative colitis115
Severe fever with thrombocytopenia syndrome virus: emerging novel phlebovirus and their control strategy115
Function of γδ T cells in tumor immunology and their application to cancer therapy114
The evolution and future of influenza pandemic preparedness111
Disease-modifying therapeutic strategies in osteoarthritis: current status and future directions110
Alternate therapeutic pathways for PARP inhibitors and potential mechanisms of resistance109
LSD1: more than demethylation of histone lysine residues104
Single-cell network biology for resolving cellular heterogeneity in human diseases90
METTL3 promotes adriamycin resistance in MCF-7 breast cancer cells by accelerating pri-microRNA-221-3p maturation in a m6A-dependent manner90
DNA end resection and its role in DNA replication and DSB repair choice in mammalian cells84
Nuciferine modulates the gut microbiota and prevents obesity in high-fat diet-fed rats81
Small but mighty: the causes and consequences of micronucleus rupture81
Cancer-associated fibroblast-secreted exosomal miR-423-5p promotes chemotherapy resistance in prostate cancer by targeting GREM2 through the TGF-β signaling pathway77
Roles of circadian clocks in cancer pathogenesis and treatment73
O-GlcNAcylation in health and neurodegenerative diseases71
Tumor microenvironment and radioresistance69
The role of neuropeptide somatostatin in the brain and its application in treating neurological disorders69
Interleukin-11 signaling underlies fibrosis, parenchymal dysfunction, and chronic inflammation of the airway67
Aurora kinase A, a synthetic lethal target for precision cancer medicine65
Mitochondrial quality control in intervertebral disc degeneration59
Gut microbiota restoration through fecal microbiota transplantation: a new atopic dermatitis therapy58
Tumor-promoting macrophages prevail in malignant ascites of advanced gastric cancer58
Organoids in image-based phenotypic chemical screens57
The m6A reader IGF2BP3 promotes acute myeloid leukemia progression by enhancing RCC2 stability57
Transcriptional regulatory network for the establishment of CD8+ T cell exhaustion54
Redefining differential roles of MAO-A in dopamine degradation and MAO-B in tonic GABA synthesis52
Spermidine attenuates bleomycin-induced lung fibrosis by inducing autophagy and inhibiting endoplasmic reticulum stress (ERS)-induced cell death in mice52
Platycodin D, a natural component of Platycodon grandiflorum, prevents both lysosome- and TMPRSS2-driven SARS-CoV-2 infection by hindering membrane fusion51
Advances in transcriptome analysis of human brain aging51
Interactions between tumor-derived proteins and Toll-like receptors50
Senescent tumor cells: an overlooked adversary in the battle against cancer50
Regulation of common neurological disorders by gut microbial metabolites49
0.22286009788513